Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contributes to the development of thyroid cancers in two different ways. Somatic rearrangements of RET with variable genes of activation are frequently found in papillary thyroid carcinomas. And Ggerm-line point mutations are responsible for the development of medullary thyroid carcinoma and the multiple endocrine neoplasia type 2(MEN2). There are several conflicting reports on the influences of RET expression and RET/PTC rearrangements on the clinical outcome of thyroid cancer. Therefore, we performed an examination of RET expression and RET/PTC-1, -2, -3 rearrangements in papillary thyroid carcinomas and other thyroid diseases. Methods: Twenty-s...
This study was designed to investigate whether RET (rearranged during transfection) mRNA over-expres...
We have recently reported the identification of a new oncogene, named PTC, frequently activated in h...
Objective: The activation of RET proto-oncogene, through different types of chromosomal transloca-ti...
Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contrib...
OBJECTIVE: RET proto-oncogene rearrangements (ret/PTCs) represent the most common genetic alteration...
Papillary thyroid carcinomas (PTCs) are the most frequent type of malignant thyroid tumors. Somatic ...
Non-thyroid neoplasia were analysed by Southern blot of genomic DNA and DNA prepared by reverse tran...
RET proto-oncogene rearrangements (RET/PTC) are causative events in the pathogenesis of a subset of ...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
Background: RET proto-oncogene rearrangements (RET/PTC) are causative events in the pathogenesis of ...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
Non-thyroid neoplasia were analysed by Southern blot of genomic DNA and DNA prepared by reverse tran...
Background: The molecular pathogenesis of hereditary medullary thyroid carcinoma is well known to be...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
We have recently reported the identification of a new oncogene, named PTC, frequently activated in h...
This study was designed to investigate whether RET (rearranged during transfection) mRNA over-expres...
We have recently reported the identification of a new oncogene, named PTC, frequently activated in h...
Objective: The activation of RET proto-oncogene, through different types of chromosomal transloca-ti...
Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contrib...
OBJECTIVE: RET proto-oncogene rearrangements (ret/PTCs) represent the most common genetic alteration...
Papillary thyroid carcinomas (PTCs) are the most frequent type of malignant thyroid tumors. Somatic ...
Non-thyroid neoplasia were analysed by Southern blot of genomic DNA and DNA prepared by reverse tran...
RET proto-oncogene rearrangements (RET/PTC) are causative events in the pathogenesis of a subset of ...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
Background: RET proto-oncogene rearrangements (RET/PTC) are causative events in the pathogenesis of ...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
Non-thyroid neoplasia were analysed by Southern blot of genomic DNA and DNA prepared by reverse tran...
Background: The molecular pathogenesis of hereditary medullary thyroid carcinoma is well known to be...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
We have recently reported the identification of a new oncogene, named PTC, frequently activated in h...
This study was designed to investigate whether RET (rearranged during transfection) mRNA over-expres...
We have recently reported the identification of a new oncogene, named PTC, frequently activated in h...
Objective: The activation of RET proto-oncogene, through different types of chromosomal transloca-ti...